Development of new atopic dermatitis models characterized by not only itching but also inflammatory skin in mice

European Journal of Pharmacology

Volumn 565, Issue 1-3, 2007, Pages 225-231

  Yatsuzuka, Rie ^a   Inoue, Toshio ^a   Jiang, Shuishi ^a   Nakano, Yoshiyuki ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Atopic dermatitis; Epicutaneous sensitization; Ovalbumin; Scratching behavior; Skin lesions

Indexed keywords

CHLORPHENIRAMINE; DEXAMETHASONE; DEXCHLORPHENIRAMINE MALEATE; EPINASTINE; HISTAMINE; NALOXONE; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; BAGG ALBINO MOUSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRY SKIN; ERYTHEMA; FEMALE; IMMUNIZATION; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; SKIN BLEEDING; SKIN EDEMA; SKIN EXFOLIATION; SKIN INFLAMMATION; SKIN PRURITUS;

ANIMALS; DERMATITIS, ATOPIC; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; HISTAMINE H1 ANTAGONISTS; IMMUNOGLOBULIN E; MICE; MICE, INBRED BALB C; NALOXONE; OVALBUMIN; PRURITUS; SKIN;

EID: 34249080644     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.062     Document Type: Article

References (24)

1. Bergasa N.V., Alling D.W., Talbot T.L., Swain M.G., Yurdaydin C., Turner M.L., and Schmitt J.M. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann. Intern. Med. 123 (1995) 161-167
2. Bernstein J.E., Swift R.M., Soltani K., and Lorincz A.L. Antipruritic effect of an opiate antagonist, naloxone chloride. J. Invest. Dermatol. 78 (1982) 82-83
3. Fujii M., Tomozawa J., Mizutani N., Nabe T., Danno K., and Kohno S. Atopic dermatitis-like pruritic skin inflammation caused by feeding a special diet to HR-1 hairless mice. Exp. Dermatol. 14 (2005) 460-468
4. Gurevitch A.W., Heiner D.C., and Reisner R.M. IgE in atopic dermatitis and other common dermatoses. Arch. Dermatol. 107 (1973) 712-715
5. Hanifin J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm. Venereol. (Stockh) 92 (1980) 44-47
6. Hikita I., Yoshioka T., Mizoguchi T., Tsukahara K., Tsuru K., Nagai H., Hirasawa T., Tsuruta Y., Suzuki R., Ichihashi M., and Horikawa T. Characterization of dermatitis arising spontaneously in DS-Nh mice maintained under conventional conditions: another possible model for atopic dermatitis. J. Dermatol. Sci. 30 (2002) 142-153
7. Jones H.E., Inouye J.C., McGerity J.L., and Lewis C.W. Atopic disease and serum immunoglobulin-E. Br. J. Dermatol. 92 (1975) 17-25
8. Kayasuga R., Sugimoto Y., Watanabe T., and Kamei C. Participation of chemical mediators other than histamine in nasal allergy signs; a study using mice lacking histamine H1 receptors. Eur. J. Pharmacol. 449 (2002) 287-291
9. Klein P.A., and Clark R.A. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch. Dermatol. 135 (1999) 1522-1525
10. Kondo H., Ichikawa Y., and Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur. J. Immunol. 28 (1998) 769-779
11. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275 (1995) 229-233
12. Kuraishi Y., Yamaguchi T., and Miyamoto T. Itch-scratch responses induced by opioids through central mu opioid receptors in mice. J. Biomed. Sci. 7 (2000) 248-252
13. Matsuda H., Watanebe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., Matsumoto M., Ushio H., Saito S., Askenase P.W., and Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9 (1997) 461-466
14. Monroe E.W. Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. J. Am. Acad. Dermatol. 21 (1989) 135-136
15. Munday J., Bloomfield R., Goldman M., Robey H., Kitowska G.J., Gwiezdziski Z., Wankiewicz A., Marks R., Protas-Drozd F., and Mikaszewska M. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology 205 (2002) 40-45
16. Ogawa M., Berger P.A., McIntyre O.R., Clendenning W.E., and Ishizaka K. IgE in atopic dermatitis. Arch. Dermatol. 103 (1971) 575-580
17. Pastar Z., Lipozencic J., and Ljubojevic S. Etiopathogenesis of atopic dermatitis - an overview. Acta Dermatovenerol. Croat. 13 (2005) 54-62
18. Stander S., and Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: an overview. Exp. Dermatol. 11 (2002) 12-24
19. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., and Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 103 (1998) 1614-1622
20. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., and Geha R.S. Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J. Clin. Invest. 103 (1999) 1103-1111
21. Ueda Y., Inoue T., Rahman M.A., Yatsuzuka R., Jiang S., and Kamei C. A new chlonic itch model accompanied by skin lesions in hairless mice. Int. Immunopharmacol. 6 (2006) 1609-1615
22. Wang L.F., Lin J.Y., and Hsieh K.H. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J. Immunol. 156 (1996) 4079-4082
23. Williams H.C., Burney P.G.J., Perbroke A.C., and Hay R.J. The U.K. Working Party's diagnostic criteria for atopic dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br. J. Dermatol. 131 (1994) 397-405
24. Yamaguchi T., Maekawa T., Nishikawa Y., Nojima H., Kaneko M., Kawakita T., Miyamoto T., and Kuraishi Y. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J. Dermatol. Sci. 25 (2001) 20-28